Références

12 mars 2020

Raoult D, Zumla A, Locatelli F, Ippolito G and Kroemer G (2020). Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress, in Press, Published 02.03.2020

Lagier JC et al, Testing the repatriated for SARS-Cov2 : should laboratory-based quarantine replace traditional quarantine?[In Press] Travel Medicine and Infectious Disease

Amrane S, Tissot-Dupont H, Doudier B, Eldin C, Hocquart M, Mailhe M, Dudouet P, Ormières E, Ailhaud L, Parola P, Lagier JC, Brouqui P, Zandotti C, Ninove L, Luciani L, Boschi C, La Scola B, Raoult D, Million M, Colson P, Gautret P. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, – January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Mar 20:101632. doi: 10.1016/j.tmaid.2020.101632. [Epub ahead of print] PubMed PMID: 32205269.

Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949. [Epub ahead of print] PubMed PMID: 32205204.

Roussel Y, Giraud-Gatineau A, Jimeno MT, Rolain JM, Zandotti C, Colson P, Raoult D. SARS-CoV-2: fear versus data. Int J Antimicrob Agents. 2020 Mar 19:105947. doi: 10.1016/j.ijantimicag.2020.105947. [Epub ahead of print] PubMed PMID: 32201354.

Baud D, Giannoni E, Pomar L, Qi X, Nielsen-Saines K, Musso D, Favre G. COVID-19 in pregnant women – Authors’ reply. Lancet Infect Dis. 2020 Mar 17. pii: S1473-3099(20)30192-4. doi: 10.1016/S1473-3099(20)30192-4. [Epub ahead of print] PubMed PMID: 32197096.

Baron SA, Devaux C, Colson P, Raoult D, Rolain JM. Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19? Int J Antimicrob Agents. 2020 Mar 13:105944. doi: 10.1016/j.ijantimicag.2020.105944. [Epub ahead of print] PubMed PMID: 32179150.

Lagier JC, Colson P, Tissot Dupont H, Salomon J, Doudier B, Aubry C, Gouriet F, Baron S, Dudouet P, Flores R, Ailhaud L, Gautret P, Parola P, La Scola B, Raoult D, Brouqui P. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar 14:101624. doi: 10.1016/j.tmaid.2020.101624. [Epub ahead of print] PubMed PMID: 32179125.

Gautret P, Al-Tawfiq JA, Hoang VT. COVID 19: Will the 2020 Hajj pilgrimage and Tokyo Olympic Games be cancelled? Travel Med Infect Dis. 2020 Mar 11:101622. doi: 10.1016/j.tmaid.2020.101622. [Epub ahead of print] PubMed PMID: 32171882.

Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 Mar 11:105938. doi: 10.1016/j.ijantimicag.2020.105938. [Epub ahead of print] PubMed PMID: 32171740.

Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020 Mar 12. pii: S1473-3099(20)30195-X. doi: 10.1016/S1473-3099(20)30195-X. [Epub ahead of print] PubMed PMID: 32171390.

Raoult D, Hsueh PR, Stefani S, Rolain JM. COVID-19 Therapeutic and Prevention. Int J Antimicrob Agents. 2020 Mar 7:105937. doi: 10.1016/j.ijantimicag.2020.105937. [Epub ahead of print] PubMed PMID: 32151714.

Parola P, Musso D. Zika, dengue, chikungunya and yellow fever infections in Europe? – Winter is over, warm days are coming – So hedge your bets. Travel Med Infect Dis. 2020 Mar 4:101614. doi:10.1016/j.tmaid.2020.101614. [Epub ahead of print] PubMed PMID: 32145385.

Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 Mar 4:105932. doi: 10.1016/j.ijantimicag.2020.105932. [Epub ahead of print] PubMed PMID: 32145363.

Favre G, Pomar L, Qi X, Nielsen-Saines K, Musso D, Baud D. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis. 2020 Mar 3. pii: S1473-3099(20)30157-2. doi: 10.1016/S1473-3099(20)30157-2. [Epub ahead of print] PubMed PMID: 32142639.

Colson P, La Scola B, Esteves-Vieira V, Ninove L, Zandotti C, Jimeno MT, Gazin C, Bedotto M, Filosa V, Giraud-Gatineau A, Chaudet H, Brouqui P, Lagier JC, Raoult D. Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 Feb;25(8). doi: 10.2807/1560-7917.ES.2020.25.8.2000171. PubMed PMID: 32127122; PubMed Central PMCID: PMC7055040.

Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020 Mar;55(3):105923. doi: 10.1016/j.ijantimicag.2020.105923. Epub 2020 Feb 15. PubMed PMID: 32070753.

Favre G, Pomar L, Musso D, Baud D. 2019-nCoV epidemic: what about pregnancies? Lancet. 2020 Feb 22;395(10224):e40. doi: 10.1016/S0140-6736(20)30311-1. Epub 2020 Feb 6. PubMed PMID: 32035511.

Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020 Mar 6:105933. doi:10.1016/j.ijantimicag.2020.105933. [Epub ahead of print] PubMed PMID: 32147516.

Colson P, Lagier JC, Baudoin JP, Bou Khalil J, La Scola B, Raoult D. Brief report: ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases. Received: 6 March 2020 /Accepted: 16 March 2020.